Fig. 3From: A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndromeChange from baseline in plasma concentrations over time and in ratio to placebo for interleukin (IL)-6 (a, b) and surfactant protein D (SP-D) (c, d). Data are expressed as adjusted median ± 95% credible interval. n* is the number of subjects available for each measurement. rhACE2 Recombinant human angiotensin-converting enzyme 2Back to article page